Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

Lignende værker

• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
  af: Taher AT, et al.
  Udgivet: (2016-12-01)
• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
  af: Taher, Ali T, et al.
  Udgivet: (2016)
• Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia
  af: Jamuar, Saumya S., et al.
  Udgivet: (2012)
• Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia
  af: Trachtenberg, Felicia, et al.
  Udgivet: (2011)
• Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
  af: Ansari, Shahla, et al.
  Udgivet: (2017)